NO20064398L - Kumarinderivat og anvendelse derav - Google Patents

Kumarinderivat og anvendelse derav

Info

Publication number
NO20064398L
NO20064398L NO20064398A NO20064398A NO20064398L NO 20064398 L NO20064398 L NO 20064398L NO 20064398 A NO20064398 A NO 20064398A NO 20064398 A NO20064398 A NO 20064398A NO 20064398 L NO20064398 L NO 20064398L
Authority
NO
Norway
Prior art keywords
ring
linear hydrocarbon
hydrocarbon group
carboxyl group
coumarin derivative
Prior art date
Application number
NO20064398A
Other languages
English (en)
Inventor
Hiroyuki Tawada
Shogo Marui
Masaki Ogino
Osamu Yabe
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20064398L publication Critical patent/NO20064398L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse angår et jordalkaliemetallsalt eller et organisk aminsalt av en forbindelse representert ved formel [I]: hvori R1 og R2 hver er et hydrogenatom, et halogenatom eller en eventuelt substituert lineær hydrokarbongruppe; ring A er en eventuelt ytterligere substituert benzenring; ring B er en eventuelt substituert benzenring; R er en karboksylgruppe eller en lineær hydrokarbongruppe substituert med en karboksylgruppe eller liknende.
NO20064398A 2004-03-02 2006-09-28 Kumarinderivat og anvendelse derav NO20064398L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004057920 2004-03-02
PCT/JP2005/003838 WO2005082879A1 (en) 2004-03-02 2005-03-01 Coumarin derivative and use thereof

Publications (1)

Publication Number Publication Date
NO20064398L true NO20064398L (no) 2006-11-08

Family

ID=34909071

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064398A NO20064398L (no) 2004-03-02 2006-09-28 Kumarinderivat og anvendelse derav

Country Status (16)

Country Link
US (1) US7541478B2 (no)
EP (1) EP1720850A1 (no)
JP (1) JP2007526237A (no)
KR (1) KR20060130189A (no)
CN (1) CN1950352A (no)
AU (1) AU2005217335A1 (no)
BR (1) BRPI0508260A (no)
CA (1) CA2557162A1 (no)
CR (1) CR8577A (no)
IL (1) IL177105A0 (no)
NO (1) NO20064398L (no)
RU (1) RU2006134614A (no)
TW (1) TW200531969A (no)
UA (1) UA84052C2 (no)
WO (1) WO2005082879A1 (no)
ZA (1) ZA200606598B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920774B1 (fr) * 2007-09-06 2009-10-30 Galderma Res & Dev Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
CN103833713B (zh) * 2008-11-28 2016-02-03 中国医学科学院药物研究所 硝克柳胺化合物晶iii型、其制法和其药物组合物与用途
CN109111478B (zh) * 2017-06-26 2021-02-26 上海日馨生物科技有限公司 苯磷硫胺衍生物、制备方法及其药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179904C (no) * 1992-09-04 1997-01-08 Takeda Chemical Industries Ltd Kondenserte heterocykliske forbindelser og deres anvendelse
EP1302470A4 (en) * 2000-07-13 2005-04-06 Takeda Pharmaceutical INHIBITORS OF PLATES RICH IN LIPID
JP2002255808A (ja) 2000-07-13 2002-09-11 Takeda Chem Ind Ltd リピド・リッチ・プラーク退縮剤
IL162810A0 (en) * 2002-01-11 2005-11-20 Takeda Pharmaceutical coumarin derivatives, process for their productionand use thereof

Also Published As

Publication number Publication date
RU2006134614A (ru) 2008-04-10
WO2005082879A1 (en) 2005-09-09
CR8577A (es) 2007-01-17
US20070197636A1 (en) 2007-08-23
KR20060130189A (ko) 2006-12-18
CN1950352A (zh) 2007-04-18
UA84052C2 (ru) 2008-09-10
JP2007526237A (ja) 2007-09-13
EP1720850A1 (en) 2006-11-15
US7541478B2 (en) 2009-06-02
TW200531969A (en) 2005-10-01
AU2005217335A1 (en) 2005-09-09
ZA200606598B (en) 2008-02-27
BRPI0508260A (pt) 2007-07-31
IL177105A0 (en) 2006-12-10
CA2557162A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
JO2791B1 (en) Acid secretion inhibitor
DE60322224D1 (de) Kondensierte heterozyklische verbindungen als petidase inhibitoren
NO983970D0 (no) Tricykliske forbindelser, deres fremstilling og anvendelse
NO20083408L (no) Korrosjonsinhibitorer som har okt biologisk nedbrytbarhet og redusert giftighet
TW200727733A (en) Moisture-reactive composition and organic electroluminescent element having same
ECSP055974A (es) Síntesis de cloruros de 4 amino-2-butenoil y su uso en la preparación de 3-ciano quinolinas
NO20073678L (no) Nye fremgangsmater for fremstilling av benzofuran
TW200602456A (en) Anthracene compound and organic electroluminescent device including the anthracene compound
MX2010008361A (es) Derivados de arilamida oxazepinopirimidona sustituidos.
TW200510377A (en) Novel compound having 4-pyridylalkylthio group as substituent
TW200722422A (en) Heterocyclic compound and organic electroluminescent device using the same
DE60025744D1 (de) Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1
WO2003059900A1 (en) Coumarin derivatives, process for their production and use thereof
AU2006232435A8 (en) BCRP/ABCG2 inhibitor
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
AR057088A1 (es) Compuestos quimicos
MX2010010471A (es) Derivado de tetrahidroisoquinolina novedoso.
CY1107101T1 (el) Μεθοδος συνθεσης παραγωγων της 1,3-διϋδρο-2h-3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης με φαρμακευτικως αποδεκτο οξυ
ATE446948T1 (de) Alpha-ketoamidderivativ, herstellungsverfahren und verwendung davon
NO20064398L (no) Kumarinderivat og anvendelse derav
DE60234117D1 (de) 2-amino-4-pyridylmethyl-thiazolinderivate und ihre verwendung als induzierbare no-synthase inhibitoren
TW200720222A (en) Hydrocarbon compound, charge-transporting material, charge-transporting material composition, and organic electroluminescent element
DK1036793T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivat og 3-aminothiophenderivat
DE602004014630D1 (de) Imidazopyridinderivate als inhibitoren der induzierbaren no-synthase
ATE423171T1 (de) Verwendung von chinaldin-und naphthalinderivaten als kristallisationsmodifikatoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application